Back
Dianthus Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
DNTH
Dianthus Therapeutics, Inc.
Last Price:
$47.37
Seasonality Move:
-0.92%
7 Day Trial
ALL ACCESS PASS
$
7
Dianthus Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Dianthus Therapeutics, Inc. has on average historically risen by 9.8% based on the past 7 years of stock performance.
-
Dianthus Therapeutics, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Dianthus Therapeutics, Inc. Stock Undervalued?The current Dianthus Therapeutics, Inc. [DNTH] share price is $47.40. The Score for DNTH is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
DNTH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Dianthus Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Dianthus Therapeutics, Inc. has on average historically risen by 9.8% based on the past 7 years of stock performance.
Dianthus Therapeutics, Inc. Stock Rating
Buy
63
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Is Dianthus Therapeutics, Inc. overpriced?
-
Dianthus Therapeutics, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Dianthus Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dianthustx.com
52-Week Data
52-Week High:
57.50
52-Week Low:
13.37
Prediction Charts
Market Cap:
2B
Price in USD:
47.40
Volume:
447.6K
Beta:
1.99
Technical Analysis
SMA50:
45.10
SMA100:
41.11
SMA200:
31.55
52-Wk Change:
96.44%
Stock Predictions
-
Is Dianthus Therapeutics, Inc. stock public?Yes, Dianthus Therapeutics, Inc. is a publicly traded company.
-
What is the Dianthus Therapeutics, Inc. stock quote today?The Dianthus Therapeutics, Inc. stock price is 47.40 USD today.
-
How to buy Dianthus Therapeutics, Inc. stock online?You can buy Dianthus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 51.45 | 50.31 | 52.02 | 50.15 |
| Jan-28 | 50.00 | 50.50 | 50.94 | 48.86 |
| Jan-29 | 51.44 | 53.36 | 54.59 | 50.79 |
| Jan-30 | 53.36 | 53.39 | 57.50 | 52.81 |
| Feb-2 | 53.25 | 53.18 | 54.17 | 52.27 |
| Feb-3 | 52.92 | 52.46 | 54.85 | 50.78 |
| Feb-4 | 52.71 | 48.13 | 52.71 | 48.00 |
| Feb-5 | 47.91 | 46.58 | 49.01 | 46.03 |
| Feb-6 | 47.57 | 50.75 | 51.44 | 47.36 |
| Feb-9 | 50.83 | 52.71 | 53.33 | 49.45 |
| Feb-10 | 53.04 | 50.82 | 53.05 | 50.62 |
| Feb-11 | 50.86 | 49.92 | 51.10 | 48.83 |
| Feb-12 | 50.10 | 47.48 | 50.10 | 45.64 |
| Feb-13 | 47.80 | 47.40 | 49.64 | 47.23 |
Dianthus Therapeutics, Inc. Earnings
Dianthus Therapeutics, Inc. Earnings Report: Per Share Dianthus Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Dianthus Therapeutics, Inc. Forecast Revenue Growth
Dianthus Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Dianthus Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.43 per share.
* Dianthus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.